Work

Improved median overall survival (OS) in patients with metastatic melanoma (mM) treated with high-dose (HD) IL-2: Analysis of the PROCLAIM 2007-2012 national registry.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.9054

Authors: Gregory A. Daniels, Michael Morse, Michael K.K. Wong, Howard Kaufman, David F. McDermott, Sandra Aung, James N. Lowder

Institutions: Moores Cancer Center, Duke Medical Center, University of Southern California, Rush University Medical Center, Beth Israel Deaconess Medical Center, Prometheus Biosciences (United States)

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2593727259

Cites:

Cited by: 5

Related to: 10